MedTrace Logo

Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence

NCT03021759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4774

Last updated 2019-06-20

Study results available
· View outcomes & findings →

Summary

In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.

Conditions

Interventions

BEHAVIORAL

Active choice

Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin

BEHAVIORAL

Social comparison feedback

Statin prescribing rates are communicated to physicians and along with how their performance compares to their peers

Sponsors & Collaborators

Principal Investigators

  • Mitesh Patel, MD, MBA, MS · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-21
Primary Completion
2017-04-21
Completion
2017-04-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03021759 on ClinicalTrials.gov